Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hiroshi Takaku is active.

Publication


Featured researches published by Hiroshi Takaku.


Tetrahedron | 1991

Solid phase synthesis of oligoribonucleotides by the phosphoramidite approach using 2′-O-1-(2-chloroethoxy)ethyl protection

Osamu Sakatsume; Tohru Yamaguchi; Masahide Ishikawa; Ichiro Hirao; Kin-ichiro Miura; Hiroshi Takaku

Abstract The new type protecting group, 1-(2-chloroethoxy)ethyl (Cee) group has been employed for the protection of the 2′-OH groups of ribonucleoside residues in the synthesis of oligoribonucleotides by the phosphoramidite approach en a solid support, using the acid-labile 5′-O-dimethaxytrityl (DMTr) group. This group is completely stable under the acidic conditions required to remove the 5t-terminal protecting groups in oligonucleotide synthesis on a solid support, and yet is easily removable under mild condition of acidic hydrolysis (pH 2.0) for the final unblocking step. The Cee-protected ribonucleoside 3′-phosphoramidite units were evaluated in the synthesis of a series of oligoribonucleotides consisting of the homopolymers of cytidine, the box 9R and 9R sequences of Tetrahymena rRNA, and a leader sequence of phage Qβ-A protein mRNA. A full data for the deprotection and purification of synthetic oligoribonucleotides are also described.


RNA | 2002

Solution structure of an RNA fragment with the P7/P9.0 region and the 3'-terminal guanosine of the tetrahymena group I intron.

Aya Kitamura; Yutaka Muto; Satoru Watanabe; Insil Kim; Takuhiro Ito; Yoichi Nishiya; Kensaku Sakamoto; Takashi Ohtsuki; Gota Kawai; Kimitsuna Watanabe; Kazumi Hosono; Hiroshi Takaku; Etsuko Katoh; Toshimasa Yamazaki; Tan Inoue; Shigeyuki Yokoyama

In the second step of the two consecutive transesterifications of the self-splicing reaction of the group I intron, the conserved guanosine at the 3 terminus of the intron (omegaG) binds to the guanosine-binding site (GBS) in the intron. In the present study, we designed a 22-nt model RNA (GBS/omegaG) including the GBS and omegaG from the Tetrahymena group I intron, and determined the solution structure by NMR methods. In this structure, omegaG is recognized by the formation of a base triple with the G264 x C311 base pair, and this recognition is stabilized by the stacking interaction between omegaG and C262. The bulged structure at A263 causes a large helical twist angle (40 +/- 80) between the G264 x C311 and C262 x G312 base pairs. We named this type of binding pocket with a bulge and a large twist, formed on the major groove, a Bulge-and-Twist (BT) pocket. With another twist angle between the C262 x G312 and G413 x C313 base pairs (45 +/- 100), the axis of GBS/omegaG is kinked at the GBS region. This kinked axis superimposes well on that of the corresponding region in the structure model built on a 5.0 A resolution electron density map (Golden et al., Science, 1998, 282:345-358). This compact structure of the GBS is also consistent with previous biochemical studies on group I introns. The BT pockets are also found in the arginine-binding site of the HIV-TAR RNA, and within the 16S rRNA and the 23S rRNA.


Nucleic acids research. Supplement (2001) | 2001

Specific inhibition of HIV-1 gene expression by double-stranded RNA

Wee-Sung Park; Naoko Miyano-Kurosaki; Emiko Nakajima; Hiroshi Takaku


Archive | 1998

Hiv cofactor inhibitor

Toru Kimura; Kazuyuki Takai; Hiroshi Takaku; Akira Wada; Naoki Yamamoto; 和田 晃; 直樹 山本; 透 木村; 洋 高久; 和幸 高井


Archive | 2001

Pharmaceutical composition for treating or preventing influenza, and novel oligonucleotide

Hiroshi Takaku; Kazuyuki Takai; Toshifumi Hatta; Tadashi Mizuta; Shiro Shigeta; Tomoyuki Yokota


Nucleic acids symposium series (2004) | 2006

HIV gene therapy using RNA virus systems.

Masaaki Hayafune; Naoko Miyano-Kurosaki; Akiko Kusunoki; Yuka Mouri; Hiroshi Takaku


Archive | 2006

Oligonucleotides labeled with stable isotopes and a method for detecting the same

Gota Kawai; Akira Wada; Hiroshi Takaku


Archive | 1999

Hiv cofactor inhibitors and medicinal compositions for preventing or treating hiv-infection

Hiroshi Takaku; Naoki Yamamoto; Toru Kimura; Kazuyuki Takai; Akira Wada


Archive | 2006

RNAi THERAPEUTIC AGENT HAVING NO ADVERSE SIDE EFFECT

Hiroshi Takaku; Naoko Kurosaki; Kazuya Yamaguchi; Takuma Gondai


Nucleic acids symposium series (2004) | 2005

Suppression of HCV RNA replication by baculovirus-mediated shRNA expression

Hitoshi Suzuki; Hiroyasu Kaneko; Nobushige Tamai; Naoko Miyano-Kurosaki; Kahoko Hashimoto; Kunitada Shimotohno; Hiroshi Takaku

Collaboration


Dive into the Hiroshi Takaku's collaboration.

Top Co-Authors

Avatar

Naoko Miyano-Kurosaki

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Kazuyuki Takai

Chiba Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Gota Kawai

Chiba Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Akira Wada

Chiba Institute of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hiroaki Takeuchi

Chiba Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Yutaka Tamura

Chiba Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Naoko Kurosaki

Chiba Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Takayuki Abe

Chiba Institute of Technology

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge